TUDOR MEDICAL CENTRE — All Prescriptions & Medications — Page 11
Practice Code: M92016 | WOLVERHAMPTON, WV10 0LS
Showing results 501-550 of 696
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 29 | 102 | £1.6K | +218.4% ▲ | |
| 29 | 205 | £421 | +20.0% ▲ | |
| 29 | 1,990 | £390 | +6.2% ▲ | |
| 29 | 2,965 | £967 | -1.3% vs avg | |
| INR blood testing reagents | 28 | 984 | £2.8K | +271.6% ▲ |
| Dorzolamide | 28 | 680 | £291 | -66.3% ▼ |
| 28 | 400 | £51 | +400.2% ▲ | |
| Cimetidine | 27 | 1,800 | £198 | +44.7% ▲ |
| Rizatriptan | 27 | 260 | £585 | -54.6% ▼ |
| Methenamine hippurate | 27 | 1,392 | £392 | -70.3% ▼ |
| Tube feed 1.5 kcal/ml (0914021) | 27 | 644.9K | £15.5K | +219.1% ▲ |
| Acetazolamide | 27 | 1,686 | £109 | +24.6% ▲ |
| Budesonide | 27 | 35 | £350 | +73.6% ▲ |
| Lidocaine | 27 | 570 | £530 | +134.9% ▲ |
| Codeine phosphate | 26 | 5,800 | £76 | +81.1% ▲ |
| Imipramine hydrochloride | 26 | 1,988 | £78 | +2.0% ▲ |
| Lisdexamfetamine dimesylate | 26 | 784 | £1.8K | -78.2% ▼ |
| Eslicarbazepine acetate | 26 | 388 | £691 | +16.5% ▲ |
| Rotigotine | 26 | 714 | £3.5K | -3.6% ▼ |
| Celecoxib | 26 | 1,290 | £67 | -60.6% ▼ |
| 26 | 280 | £919 | -15.4% ▼ | |
| Linaclotide | 25 | 756 | £964 | +36.8% ▲ |
| Metronidazole | 25 | 1,000 | £103 | +278.0% ▲ |
| Water for injection | 25 | 410 | £125 | -26.1% ▼ |
| Cinacalcet hydrochloride | 25 | 770 | £198 | +7.8% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 25 | 21.3K | £328 | +9.1% ▲ |
| 25 | 1,820 | £982 | -32.7% ▼ | |
| 25 | 740 | £659 | +45.2% ▲ | |
| Cenobamate | 24 | 672 | £3.3K | -0.9% vs avg |
| Ins degludec/liraglutide | 24 | 96 | £3.1K | +49.3% ▲ |
| Metformin hydrochloride/vildagliptin | 24 | 2,192 | £1.2K | +46.9% ▲ |
| Azelastine hydrochloride | 24 | 200 | £152 | +101.9% ▲ |
| 24 | 1,020 | £561 | +132.4% ▲ | |
| Zolpidem tartrate | 23 | 644 | £29 | -74.5% ▼ |
| Powder thickener - gum based (0913161) | 23 | 10.2K | £558 | -69.4% ▼ |
| Powder disc or non ACBS lactose free formula (0913352) | 23 | 37.2K | £742 | +195.3% ▲ |
| Tafluprost | 23 | 690 | £281 | +24.0% ▲ |
| Malathion | 23 | 3,750 | £342 | +260.1% ▲ |
| Tetracaine | 23 | 63 | £65 | +162.5% ▲ |
| 23 | 480 | £108 | +56.3% ▲ | |
| Ofloxacin | 22 | 634 | £752 | +167.7% ▲ |
| Vardenafil | 22 | 264 | £520 | +57.6% ▲ |
| Tacrolimus | 22 | 1,818 | £3.7K | -17.7% ▼ |
| Magnesium aspartate | 22 | 1,702 | £1.5K | +45.3% ▲ |
| Aluminium chloride | 22 | 1,280 | £179 | +171.4% ▲ |
| 22 | 6,360 | £75 | -12.5% ▼ | |
| 22 | 24 | £180 | +254.8% ▲ | |
| Ciprofibrate | 21 | 441 | £1.1K | +57.2% ▲ |
| Bempedoic acid/Ezetimibe | 21 | 1,176 | £2.2K | -65.6% ▼ |
| Rimegepant | 21 | 332 | £4.3K | +114.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.